$7.85—Stale · 3 weeks old
NASDAQ • Last print 3 weeks ago
$7.85—Stale · 3 weeks old
Key Metrics
TTMMarket Cap$10.91M
Revenue TTM—
Price / Sales—
Net Income TTM—
Free Cash Flow—
Gross Margin74.0%
Operating Margin228199205.0%
Net Margin733250187.2%
Return on Equity-275.7%
Return on Assets-93571.1%
Debt / Equity (MRQ)0.00
Current Ratio (MRQ)27.40
EPS TTM$-3882.99
PRICE
Prev Close
6.05
Open
6.26
Day Range5.63 – 7.85
5.63
7.85
52W Range1.84 – 8.94
1.84
8.94
85% of range
50-Day MA
6.28(+25.0%)
200-Day MA
4.56(+72.1%)
VOLUME & SIZE
Avg Volume
933.1K
FUNDAMENTALS
P/E (TTM)
-1.1x
Not profitable
EPS (TTM)
—
Div Yield (TTM)
No dividend
TECHNICAL
RSI (14)
49
Bearish momentum
Upcoming Events
DEx-Dividend
In 90 days
Nov 30
PDividend Pay
In 90 days
Nov 30
SNPX News
About
synaptogenix is a clinical-stage biopharmaceutical company that has historically worked to develop novel therapies for neurodegenerative diseases.
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Alan J. TuchmanChief Executive Officer & Director
Daniel L. AlkonPresident, Chief Scientific Officer & Director
Robert WeinsteinChief Financial Officer, Executive Vice President, Treasurer & Secretary